Key points – High expression of FOXP1 predicts adverse failure free survival in patients with follicular lymphoma treated with immunochemotherapy. FOXP1 high and low expressors differ in specific gene mutations and gene expression changes.
Home / Resource Library / FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy